The Fate of Nanocarriers As Nanomedicines In Vivo: Important Considerations and Biological Barriers to Overcome

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|20|22|2759-2778

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.20, Iss.22, 2013-07, pp. : 2759-2778

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Relevant Physicochemical Descriptors of “Soft Nanomedicines” to Bypass Biological Barriers

By  

Current Pharmaceutical Design, Vol. 22, Iss. 9, 2016-03 ,pp. : 1274-1291

Bentham Science Publishers

Access to resources Recommend Favorite

Drug-Loaded Nanocarriers: Passive Targeting and Crossing of Biological Barriers

By  

Current Medicinal Chemistry, Vol. 19, Iss. 19, 2012-01 ,pp. : 3070-3102

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluation of the Biological Fate and the Transport Through Biological Barriers of Nanosilver in Mice

By  

Current Pharmaceutical Design, Vol. 19, Iss. 37, 2013-11 ,pp. : 6691-6697

Bentham Science Publishers

Access to resources Recommend Favorite

Engineering Nanomedicines to Overcome Multidrug Resistance in Cancer Therapy

By  

Current Medicinal Chemistry, Vol. 23, Iss. 1, 2016-01 ,pp. : 3-22

Bentham Science Publishers

Access to resources Recommend Favorite

Biological rationale for the design of polymeric anti-cancer nanomedicines

By Zhou Yan   Kopeček Jindřich  

Journal of Drug Targeting, Vol. 21, Iss. 1, 2013-01 ,pp. : 1-26

Informa Healthcare

Access to resources Recommend Favorite